team – ANSEA

ANSEA - THE DREAM TEAM

At the heart of our success lies our team of experts

From seasoned veterans with decades of industry experience to rising stars with fresh perspectives, our team is united by a shared passion for innovation and a commitment to excellence.

With diverse backgrounds and expertise spanning the healthcare industry, our team members bring a broad range of perspectives and insights to each and every project. But what truly sets our team apart is their unwavering dedication to our clients. At the end of the day, our team is the backbone of our success. They are the driving force behind everything we do, and we couldn’t be more proud to have them on board.

The Driving Force
Our Steering Committee

Anand Jha

Managing Director

Anand is responsible for the corporate strategy, business development and overall operations of the firm.

He is a healthcare industry veteran with many years of multidisciplinary experience in pharma and medical devices. He was the Head of Market Access & Government Affairs Asia/Russia and General Manager for Alcon at Singapore. His previous responsibilities ran ge from sales, marketing, strategic planning, pricing and market access, and general management at global and regional levels, primarily in Novartis. In the past, he has been the global value & access director and global head of marketing and sales services for Novartis, based in Basel

Anand is an engineer with a Masters in International Business from IIFT, India and MBA from IMD, Switzerland.

Diego Ossa

Executive Director

Diego-Ossa is a physician and health economist with over 25 years of experience spanning clinical practice, consultancy, and leadership roles in the pharmaceutical industry.

Based in Switzerland, he has held senior positions at Novartis, where he led global market access and evidence generation strategies across a wide range of therapeutic areas, including rare and general diseases. Diego’s expertise lies in integrating clinical development with payer-aligned strategies to optimize patient access.

His work has contributed to the successful launch of major therapies such as Xolair and Entresto. He brings a
unique perspective shaped by experience as a UK payer and strategic leader.

Angela Murray

Principal Consultant

Angela is a senior healthcare leader in with over 30yrs experience in sales, marketing, business redesign, market development, market access and healthcare economics.

Her industry experience entails a long stint with Baxter, leading their global market access and HEOR team and working with regional and local teams globally to drive reimbursement and funding of Baxter products. She has led numerous strategic market assessments, guided country growth plans, overseen development of payor and provider value dossiers, cost calculators / budget impact models, policy workshops and market access capability building initiatives.

Angela has worked primarily in Canada country organization and global teams in the US. She has a Master’s in nursing administration from University of Toronto, Canada.

Anand Jha

Managing Director

Anand is responsible for the corporate strategy, business development and overall operations of the firm.

He is a healthcare industry veteran with many years of multidisciplinary experience in pharmaceuticals and medical devices. He was the Head of Market Access and Government Affairs Asia/Russia and General Manager for Alcon at Singapore. His previous responsibilities range from sales, marketing, strategic planning, pricing and market access, and general management at global and regional levels, primarily in Novartis.

Anand is an engineer with a Masters in International Business from IIFT, India and MBA from IMD, Switzerland.

David Lin

Business Director

South East Asia

David is responsible for overseeing ANSEA operations for SE Asia.

He has worked in different functions in his career spanning more than 20 years – sales, marketing, business unit management, market access, policy, communications, government affairs, and key accounts – across various multinational corporations such as Pfizer, AZ, Bayer, Sanofi, Novartis, MSD and GSK. His leadership roles include those of business unit director, head of market access and director communications, government affairs and strategic customer solutions.

David has a Bachelors of Science with an MBA from Australia and a Public Policy specialization from London School of Economics.

Jaganmohan Verma

Senior Director

HTA / HEOR / RWE

Jagmohan Verma is the Senior Director at ANSEA, leading our HTA / HEOR modelling practice and brings over 17 years of diverse experience in the pharmaceuticals and medical devices industries.

Jagmohan’s expertise spans Health Economics and Outcomes Research (HEOR), Real-World Evidence (RWE) data analysis, and Health Technology Assessment (HTA) research and development. He has worked with multiple global consulting firms such as Heron Health, Parexel, Capita, BresMed, and ZS Associates, where he led and managed projects focused on economic model development and adaptation, systematic literature reviews, meta-analyses, and real-world data analysis. His experience includes working with databases like SEER, KNHANES, NHIRD, and Optum, and he is proficient in using SAS and R software for data analysis.

Jagmohan has been an invited speaker at numerous industry and academic forums, is a published author in academic journals, and has served as a mentor to Master’s students in Pharmacy. He holds a Master’s degree in Pharmaceutical Sciences from NIPER Mohali, India.

Dev Madeka

Senior
Director

Dev is a seasoned senior executive bringing over 20 years of diverse experience across the pharmaceutical landscape, encompassing innovative medicines, generics, and OTC products within Australia, India, and Southeast Asia.

His expertise spans Commercial Excellence and Go-to-Market strategy, Market Research and Opportunity Assessment, Sales Force Excellence, Marketing Analytics and Insights, Digital and Omni-channel Marketing, Lean Six Sigma methodologies, and Digital Health Initiatives. Throughout his career, Dev has spearheaded numerous transformation projects at the intersection of technology and customer experience. He has provided strategic counsel on Launch Excellence and Go-to-Market strategies for multiple Asian markets.

Dev is an Engineer with an MBA from Indian School of Business

Anand Jha

Managing Director

David Lin

Business Director

South East Asia

David is responsible for overseeing ANSEA operations for SE Asia.

David has a Bachelors of Science with an MBA from Australia and a Public Policy specialization from London School of Economics.

Jaganmohan Verma

Senior Director

HTA / HEOR / RWE

Jagmohan Verma is the Senior Director at ANSEA, leading our HTA / HEOR modelling practice and brings over 17 years of diverse experience in the pharmaceuticals and medical devices industries.

Vasudha Mukherjee

Principal Consultant

Vasudha is responsible for guiding and leading projects related to health economic modelling, HTA submissions, global value dossiers and policy briefs, as well as managing the clients based in North America.

She is a Market Access/HEOR professional with over 20 years of experience in developing and executing market access/HEOR strategies to support launch and enable access and reimbursement. Her experience spans across the biopharma and medical devices/diagnostics portfolio, in creating and demonstrating value, partnering with external data and clinician partners, working on early pricing strategies, and contracting to meet evolving needs of payers/HTA agencies globally. With the focus on the US, she has also successfully supported reimbursement for several EU and Asian countries including China and Korea. Vasudha has worked on several position papers to help shape health policies, by engaging with external policymakers, industry associations, and advocacy groups.

Vasudha has a Masters in Physiology from University of Calcutta, India and MBA from ICFAI Business School, India.